ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Rhoen Klinikum AG (PK)

Rhoen Klinikum AG (PK) (RKAGY)

6.05
0.00
(0.00%)
Closed January 05 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
6.05
Bid
6.04
Ask
7.59
Volume
-
0.00 Day's Range 0.00
5.41 52 Week Range 6.51
Market Cap
Previous Close
6.05
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
133,876,940
Dividend Yield
-
PE Ratio
48.06
Earnings Per Share (EPS)
0.29
Revenue
1.74B
Net Profit
38.71M

About Rhoen Klinikum AG (PK)

Sector
Gen Med & Surgical Hospitals
Industry
Health Care Facilities Diverse
Headquarters
Bad Neustadt An Der Saale, Deu
Founded
1988
Rhoen Klinikum AG (PK) is listed in the Gen Med & Surgical Hospitals sector of the OTCMarkets with ticker RKAGY. The last closing price for Rhoen Klinikum (PK) was $6.05. Over the last year, Rhoen Klinikum (PK) shares have traded in a share price range of $ 5.41 to $ 6.51.

Rhoen Klinikum (PK) currently has 133,876,940 shares outstanding. The market capitalization of Rhoen Klinikum (PK) is $809.96 million. Rhoen Klinikum (PK) has a price to earnings ratio (PE ratio) of 48.06.

RKAGY Latest News

Rhoen-Klinikum Proposes Higher Dividend, Further Buyback

By Ulrike Dauer FRANKFURT--German private hospital operator Rhoen-Klinikum AG (RHK.XE) said on Thursday it is proposing a higher dividend for 2014 and plans to buy back more shares. Both measures...

Fresenius SE to Issue More Notes to Fund Rhoen Hospitals Acquisition

German healthcare group Fresenius SE & Co. KGaA (FRE.XE) said Tuesday it intends to issue EUR200 million of senior unsecured notes to fund the acquisition of hospitals from rival...

Fresenius SE to Issue More Notes to Fund Rhoen Hospitals Acquisition

German healthcare group Fresenius SE & Co. KGaA (FRE.XE) said Tuesday it intends to issue EUR200 million of senior unsecured notes to fund the acquisition of hospitals from rival...

Fresenius Finalizing Deal to Buy Rhoen-Klinikum Hospitals

Fresenius SE & Co. KGaA (FRE.XE) Monday said it expects to finalize the purchase of Rhoen-Klinkum AG (RHK.XE) hospital and outpatient facilities early next year. MAIN FACTS: -Fresenius said...

B. Braun Files Lawsuit Against Rhoen-Klinikum, Helios Transaction

German hospital operator Rhoen-Klinikum AG (RHK.XE) late Thursday said that its shareholder B. Braun Melsungen AG has filed a lawsuit against the sale of 43 clinics to Fresenius SE (FRE.XE) unit...

Rhoen-Klinikum Investor Favors Share Buyback

Proceeds from the sale of most of Rhoen-Klinikum AG's (RHK.XE) clinics should be used to cut debt and buy back shares, large investor Eugen Muench said in an interview with the Sueddeutsche...

Fresenius 3Q Sales Increase, 2013 Outlook Confirmed

Fresenius SE & Co. KGaA (FRE.XE) confirmed full-year guidance after all business segments contributed to increased sales in the third quarter. Sales rose to 5.05 billion euros ($6.82 billion...

Rhoen-Klinikum Shareholders to Benefit from Hospital Sales - Report

Rhoen-Klinikum AG (RHK.XE) shareholders should expect to benefit financially from the sale of several hospitals to German healthcare company Fresenius SE & Co. KGaA (FRE.XE), its chairman said...

EUROPE MARKETS: European Stocks Edge Higher After U.S. Data

By Sara Sjolin, MarketWatch COPENHAGEN (MarketWatch) -- European stock markets ended slightly higher on Friday, as investors tried to gauge whether the latest U.S. economic data would weaken or...

EUROPE MARKETS: European Stocks Wobble After U.S. Data

By Sara Sjolin, MarketWatch MADRID (MarketWatch) -- European stock markets struggled for direction on Friday, as investors tried to gauge whether U.S. data would weaken or strengthen the case for...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
26006.056.056.0500DR
520.6411.82994454715.416.515.41685.94921569DR
156-2.65-30.45977011498.78.75.41956.42210909DR
260-3.615-37.40300051739.66510.35.4111069.38386369DR

RKAGY - Frequently Asked Questions (FAQ)

What is the current Rhoen Klinikum (PK) share price?
The current share price of Rhoen Klinikum (PK) is $ 6.05
How many Rhoen Klinikum (PK) shares are in issue?
Rhoen Klinikum (PK) has 133,876,940 shares in issue
What is the market cap of Rhoen Klinikum (PK)?
The market capitalisation of Rhoen Klinikum (PK) is USD 809.96M
What is the 1 year trading range for Rhoen Klinikum (PK) share price?
Rhoen Klinikum (PK) has traded in the range of $ 5.41 to $ 6.51 during the past year
What is the PE ratio of Rhoen Klinikum (PK)?
The price to earnings ratio of Rhoen Klinikum (PK) is 48.06
What is the cash to sales ratio of Rhoen Klinikum (PK)?
The cash to sales ratio of Rhoen Klinikum (PK) is 1.07
What is the reporting currency for Rhoen Klinikum (PK)?
Rhoen Klinikum (PK) reports financial results in EUR
What is the latest annual turnover for Rhoen Klinikum (PK)?
The latest annual turnover of Rhoen Klinikum (PK) is EUR 1.74B
What is the latest annual profit for Rhoen Klinikum (PK)?
The latest annual profit of Rhoen Klinikum (PK) is EUR 38.71M
What is the registered address of Rhoen Klinikum (PK)?
The registered address for Rhoen Klinikum (PK) is SCHLOSSPLATZ 1, BAD NEUSTADT AN DER SAALE, 97616
What is the Rhoen Klinikum (PK) website address?
The website address for Rhoen Klinikum (PK) is www.rhoen-klinikum-ag.com
Which industry sector does Rhoen Klinikum (PK) operate in?
Rhoen Klinikum (PK) operates in the HEALTH CARE FACILITIES DIVERSE sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EGIOQEdgio Inc (CE)
$ 0.01
(999,900.00%)
584
AAGRAfrican Agriculture Holdings Inc (CE)
$ 0.008
(799,900.00%)
477
THCBFTHC Biomed International Limited (CE)
$ 0.001
(99,900.00%)
100
AEORFAEON REIT Investment Corporation (PK)
$ 796.08
(26,436.00%)
1
EFTReFFECTOR Therapeutics Inc (CE)
$ 0.0002
(19,900.00%)
225
UFABQUnique Fabricating Inc (CE)
$ 0.000001
(-99.98%)
102.53k
VICFFVice Health and Wellness Inc (CE)
$ 0.000001
(-99.97%)
996
SAFSSafer Shot Inc (CE)
$ 0.000001
(-99.93%)
2.54M
ERFBERF Wireless Inc (CE)
$ 0.0001
(-99.89%)
99.77k
ARVLFArrival (CE)
$ 0.0002
(-99.60%)
42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)
$ 0.0038
(52.00%)
608.97M
HMBLHUMBL Inc (PK)
$ 0.0009
(0.00%)
546.25M
PHILPHI Group Inc (PK)
$ 0.0003
(0.00%)
501.07M
CBIACanopus Biopharma Inc (PK)
$ 0.0002
(100.00%)
281.95M
RDARRaadr Inc (PK)
$ 0.00125
(-10.71%)
169.44M

Discussion

View Full Feed
marcis marcis 5 minutes ago
You obviously overlook the fact of the billion shares bought up at .001 avg

And a single $100k trade

Next
RDAR
catdaddy catdaddy 5 minutes ago
Drink much?
AVXL
MomsSpaghetti MomsSpaghetti 6 minutes ago
We go over 5.00 this will hit 10.00 very fast be ready.
ATAI
MomsSpaghetti MomsSpaghetti 7 minutes ago
Get ready for launch!
ASST
MakeItRain88 MakeItRain88 8 minutes ago
If I haven't been able to recognize a loss for two years in a row since bankruptcy, I have a case.
MSLPQ
dstock07734 dstock07734 8 minutes ago
Have you seriously considered my suggestion of treating this investment as statically indeterminate systems to find out if the solution is truly amazing? I already provided a bunch of stuff you could use as compatibility conditions.

You think by throwing out some strange terminologie
NWBO
tdbowieknife tdbowieknife 9 minutes ago
It's dual listed... WHY is this so hard??? Both Canadian and US regulators have jurisdiction.

Geezzzzess fricking Christ...


..


.
TWOH
flipper44 flipper44 9 minutes ago
No. Twit.
NWBO
marcis marcis 9 minutes ago
None just move on


Which accounts. I should follow them. $RDAR

RDAR
MomsSpaghetti MomsSpaghetti 10 minutes ago
Can we be done with the bickering.... please. Keep it on track. We have a good year ahead of us. We will all do well. Relax.
MNMD
gp22 gp22 10 minutes ago
$SYNX: Israel play. Total shares 5.3M. Owned 85% by Insiders & Funds...Has $NITO type potential this week. Every Isreal play that gets found has ripped big. $SYNX started getting action Friday last.
NITO SYNX SYNXSTARTE
gp22 gp22 11 minutes ago
$SYNX: Israel play. Total shares 5.3M. Owned 85% by Insiders & Funds...Has $NITO type potential this week. Every Isreal play that gets found has ripped big. $SYNX started getting action Friday last.
NITO SYNX SYNXSTARTE
govprs govprs 11 minutes ago
Maybe they should release a paper about this asap.  All the chickens and cattle shortages are driving up prices like crazy.  
BIXT
nowwhat2 nowwhat2 11 minutes ago
WHY SO HARD DROP RIGHT BACK DOWN ?........

https://investorshub.advfn.com/uimage/uploads/2025/1/5/ckgzmtotal_!_5_CAPT_7pm_XRP_RESIST.jpg




https://investorshub.advfn.com/uimage/uploads/2025/1/5/ouvwitotal_!_5_3m_7pm_RESIST.jpg

XRPUSD
jgrabar jgrabar 11 minutes ago
https://markets.businessinsider.com/news/stocks/grabar-law-office-investigates-claims-on-behalf-of-current-longterm-shareholders-of-expensify-inc.-exfy-1034177507

Philadelphia, Pennsylvania--(Newsfile Corp. - December 29, 2024) - Grabar Law Office is investigating whether certain offi
EXFY
Sideem Sideem 13 minutes ago
Could be.   It looks to be another piece of the rebranding puzzle.   
BB
marcis marcis 13 minutes ago
Totally agree he should be on a George Sharp board with his never ending LOi’s
But seems to always run his stock
RDAR
Hi_Lo Hi_Lo 13 minutes ago
Many other things are happening behind the scenes!!
Such as?
BCAP
govprs govprs 15 minutes ago
I think he's trying to buy more shares at lower prices.  One day he will stop.
GDVM
wyobuford wyobuford 17 minutes ago
I must have transposed something on a pick as I have cash instead of NVEC.  If so, I would like to trade for NVEC.  Thanks and have a great evening. 
marcis marcis 17 minutes ago
Friday Dec 27 2024at the end of the trading session, Mexedia held a meeting of the board to approve filing 2024 financials by April 29

You know the SEC has changed its guidance for auditing only on Dec 15
RDAR
dstock07734 dstock07734 18 minutes ago
Truthfan,

Keep in mind the following.

Merck & Co., Inc. Q4 2024 Earnings Call February 4, 2025 9:00 am EST
NWBO
govprs govprs 19 minutes ago
Looks promising.  I hope they get a peer review or start more in depth trials.  Ty for sharing 
BIXT